Product Program year 2025 Source: CMS Open Payments

VersaCross Access Solution

Device VersaCross Access Solution_ICG

PDI 00685447007555

Open in the dashboard

General payments

$1,109,113

3,959 payments

Research payments

$0

0 payments

Through program year 2025, $1,109,113 in general payments and $0 in research payments were reported against VersaCross Access Solution (VersaCross Access Solution_ICG).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $420,346 1,132
2024 General $573,082 2,024
2023 General $115,685 803

Breakdown

Who paid General payments · program years 2023–2025
  1. Boston Scientific Corporation $1,109,113 3,959 payments
Top recipients General payments · program year 2025
  1. Augustin Delago Cardiovascular Disease · Albany, NY $67,705 16% · 25 payments
  2. Jason Chinitz Bay Shore, NY $27,569 7% · 8 payments
  3. Matthew Hyman Clinical Cardiac Electrophysiology · Philadelphia, PA $18,775 4% · 4 payments
  4. David Callans Clinical Cardiac Electrophysiology · Philadelphia, PA $17,248 4% · 7 payments
  5. Megan Coylewright Interventional Cardiology · Calhoun, GA $15,047 4% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Interventional Cardiology Internal Medicine $150,884 39% · 92 practitioners
  2. Cardiovascular Disease Internal Medicine $120,931 31% · 91 practitioners
  3. Clinical Cardiac Electrophysiology Internal Medicine $95,971 25% · 83 practitioners
  4. Internal Medicine $12,924 3% · 25 practitioners
  5. Physician Assistant $1,752 <1% · 14 practitioners

The top 5 of 31 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $130,607 31% · 74 recipients
  2. Pennsylvania $36,466 9% · 10 recipients
  3. Texas $35,670 8% · 33 recipients
  4. California $31,114 7% · 15 recipients
  5. Georgia $25,500 6% · 8 recipients

The top 5 of 45 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

3,959 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record